0
The Children’s Hospital of Philadelphia and BGI Announce Partnership and New Joint Genome Center to Target Pediatric Diseases
Publish Date: 2011-11-09
Philadelphia, Pa. and Shenzhen, China, Nov. 9, 2011 — The Children’s Hospital of Philadelphia and BGI, the world’s largest genomics institute, today announced they have formed a partnership, BGI@CHOP, to conduct large-scale human genome sequencing and bioinformatics analysis at a newly established, state-of-the-art Joint Genome Center at Children’s Hospital. The partnership will focus on the discovery of genes underpinning rare and common pediatric diseases using next-generation sequencing. The Center became fully operational last month.

 

The BGI@CHOP partnership will bring together the unique strengths of two world-class institutions. BGI’s capabilities and expertise in whole genome sequencing and analysis, combined with Children’s Hospital’s extensive biobank and expertise in clinical phenotyping, will allow scientists and clinicians to harness the power of large, detailed data sets to improve the lives of patients and families.

 

“The Children’s Hospital of Philadelphia has built the largest pediatric biobank in the world, and because many of these samples have been linked to clinical data using an electronic medical record, we can now follow disease processes into adulthood,” said Hakon Hakonarson, M.D., Ph.D., Director of the Center for Applied Genomics at Children’s Hospital. “Through our partnership with BGI, we now have a clear path forward into the genomics-based personalized medicine arena.”

 

“We are very excited about this new partnership with BGI,” said Philip Johnson, M.D., Chief Scientific Officer at The Children’s Hospital of Philadelphia. “It is an ideal collaboration between two world-class institutions. The ultimate goal is to change the way we diagnose and treat diseases that affect children and families, and our work with BGI is an important first step toward that end.”

 

“This new partnership will accelerate the discovery of genetic variants underpinning rare and common pediatric diseases by joining the forces of one of the best pediatric hospitals in the world with the world’s largest genomics institute,” said Jun Wang, Executive Director of BGI.

 

“We look forward to a productive relationship with The Children’s Hospital of Philadelphia, a global leader in pediatric care and research,” stated Greg Wang, Chief Executive Officer of BGI Americas. “Given BGI’s expertise in genomic sequencing and bioinformatics, we expect our partnership with Children’s Hospital and the establishment of the BGI@CHOP Joint Genome Center to lead to significant breakthroughs that may be translated into improved patient care.”

 

About The Children’s Hospital of Philadelphia

 

The Children’s Hospital of Philadelphia was founded in 1855 as the first pediatric hospital in the United States. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children’s Hospital has fostered many discoveries that have benefited children worldwide and its pediatric research program is among the largest in the U.S. In addition, its unique family-centered care and public service programs have brought the 516-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.

 

Contact Information:

 

John Ascenzi

 

Public Relations Department

 

The Children’s Hospital of Philadelphia

 

267-426-6055

 

ascenzi@email.chop.edu

 

Joyce Peng, Ph.D.

 

Marketing Director

BGI Americas Corporation

626-222-5584

 

 

www.bgiamericas.com

 

Bicheng Yang

 

Public Communication Officer

 

BGI

 

+86-755-82639701

 

 

www.genomics.cn